Join Bloomberg Intelligence to cover recent innovations in biotechnology, hosted by Senior Analyst Asthika Goonewardene. The session will kick off with a discussion on the driving forces of the biotech market. A panel on CAR-T will explore the burning questions around adoptive T cell therapies that are driving the remarkable ascension of the space. A second panel will delve into Gene Editing, a hot new potential frontier for the biotech drug discovery that is gaining the attention of pharma and investors alike. The morning will be capped off with a talk on financing.

Further details on panel members to follow.

Complimentary breakfast will be served during the beginning of our program.